Annex A: SSPs issued to date
Published 27 May 2021
© Crown copyright 2021
This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit nationalarchives.gov.uk/doc/open-government-licence/version/3 or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: psi@nationalarchives.gov.uk.
Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.
This publication is available at https://www.gov.uk/government/publications/serious-shortage-protocols-one-year-policy-review/annex-a-ssps-issued-to-date
| SSP | Alternative | Issued | Ended | Times used | Notes |
|---|---|---|---|---|---|
| SSP01 Fluoxetine 10mg capsules | 1 x 10mg fluoxetine tablet or 2.5ml of fluoxetine 20mg/5ml oral solution SF or 2.5ml of fluoxetine 20mg/5ml oral solution | 3 Oct 2019 | 25 Oct 2019 | 2,844* | England only. Withdrawn early due to supply improvement |
| SSP02 Fluoxetine 30mg capsules | 1 x 10mg fluoxetine tablet, plus 1 x 20mg fluoxetine capsule | 3 Oct 2019 | 18 Dec 2019 | 2,844* | England only. SSP was extended from the original end date of 31 October 2019 to 20 November 2019 and again until 18 December 2019 and varied to change the alternative that could be supplied |
| SSP03 Fluoxetine 40mg capsules | 2 x 20mg fluoxetine capsules | 3 Oct 2019 | 20 Nov 2019 | 2,844* | England only. SSP was extended from the original end date of 31 October 2019 |
| SSP04 Haloperidol (Serenace®) 500mcg capsules | 1 x 500 microgram haloperidol tablet | 23 Dec 2019 | 23 Mar 2020 | 2,065 | England and Wales |
| SSP05 Fluoxetine 10mg tablets | 1 x fluoxetine 10mg capsule | 12 Mar 2020 | - | * | England, Wales and Northern Ireland. SSP was extended from the original end date of 12 Jun 2020 to 17 May 2021 |
| SSP06 Fluoxetine 40mg capsules | 2 x 20mg fluoxetine capsules | 20 May 2020 | 2 Oct 2020 | * | England, Wales and Northern Ireland. SSP was extended from the original end date of 20 Jul 2020 to 2 Oct 2020 |
| SSP007 Fluoxetine 30mg capsules | 1 x fluoxetine 20mg capsule plus 1 x fluoxetine 10mg capsule or 3 x fluoxetine 10mg capsules | 20 Oct 2020 | - | * | England and Wales. SSP was extended from the original end date of 22 Dec 2020 to 17 May 2021 |
| SSP008 Salazopyrin® EN-Tabs 500mg | 1 x Sulfasalazine 500mg gastro-resistant (GR) tablet | 20 Oct 2020 | 8 Mar 2021 | TBC | England and Wales. SSP was extended from the original end date of 4 Dec 2020 to 8 Mar 2021 |
| SSP009 Fluoxetine 40mg capsules | 2 x 20mg fluoxetine capsules | 29 Jan 2021 | - | TBC | England, Wales and Northern Ireland. SSP was extended from the original end date of 31 Mar 2021 to 17 May 2021 |
| SSP010 Levothyroxine 12.5 microgram tablets | 1 x levothyroxine 25 microgram tablet to be taken on alternate days | 3 Feb 2021 | 1 Apr 2021 | TBC | England, Wales and Scotland. SSP was extended from the original end date of 21 Mar 2021 |
| SSP011 Competact 15mg/850mg tablets | 1 x pioglitazone 15mg tablet plus 1 x metformin 850mg tablet | 24 Mar 2021 | 14 May 2021 | TBC | England Wales and Scotland. SSP was extended from the original end date of 7 May 2021 |
| Estradot® 75 microgram patches | Evorel® 75 microgram patches or Estraderm MX® 75 microgram patches | 29 Apr 2021 | - | TBC | England and Wales |
*Because several fluoxetine SSPs have run simultaneously it is not possible with the available data to determine specifically which fluoxetine SSP was being used – for example, 10mg fluoxetine capsules were an option to be supplied in accordance with SSP05, SSP06 and SSP007.